Galectin Therapeutics Inc. (GALT)
USD 1.42
(10.08%)
USD 1.42
(10.08%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 33 Thousand | 32 Thousand | 41 Thousand | 36 Thousand | 35 Thousand | - |
| Gross Profit | -33 Thousand | -32 Thousand | -41 Thousand | -36 Thousand | -35 Thousand | - |
| Operating Expenses | 38.07 Million | 38.35 Million | 30.17 Million | 23.44 Million | 13.43 Million | 13.6 Million |
| Selling, General and Administrative Expenses | 5.94 Million | 6.61 Million | 6.36 Million | 5.46 Million | 5.97 Million | 7.13 Million |
| Research and Development Expenses | 32.13 Million | 31.73 Million | 23.81 Million | 17.97 Million | 7.46 Million | 6.47 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 38.07 Million | 38.35 Million | 30.17 Million | 23.44 Million | 13.43 Million | 13.6 Million |
| Operating Income | -38.07 Million | -38.35 Million | -30.17 Million | -23.44 Million | -13.43 Million | -13.6 Million |
| Interest Expense | 2.56 Million | 1.03 Million | 489 Thousand | 87 Thousand | 87 Thousand | 336 Thousand |
| Income Tax Expense | - | 424 Thousand | 448 Thousand | 51 Thousand | 87 Thousand | -123.14 Thousand |
| Earnings before Tax | -41.06 Million | -38.77 Million | -30.52 Million | -23.46 Million | -13.29 Million | -13.9 Million |
| Net Income | -41.06 Million | -39.2 Million | -30.97 Million | -23.51 Million | -13.38 Million | -13.9 Million |
| Earnings Per Share Basic | -0.74 | -0.66 | -0.53 | -0.41 | -0.26 | -0.35 |
| Earnings Per Share Diluted | -0.74 | -0.66 | -0.53 | -0.41 | -0.26 | -0.35 |
| Weighted Average Shares Outstanding | 60.15 Million | 59.39 Million | 58.52 Million | 57.02 Million | 52.23 Million | 39.41 Million |
| Weighted Average Shares Outstanding (Diluted) | 60.15 Million | 59.39 Million | 58.52 Million | 57.02 Million | 52.23 Million | 39.41 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -202 Thousand | -37.71 Million | -29.99 Million | -23.34 Million | -13.17 Million | -13.56 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 80 Thousand | - | - |
| Cost of Revenue | 9000.00 | 9000.00 | 33 Thousand | 9000.00 | 8000.00 | - |
| Gross Profit | -9000.00 | -9000.00 | -33 Thousand | 71 Thousand | -8000.00 | - |
| Operating Expenses | 11.28 Million | 9.63 Million | 38.03 Million | 9.55 Million | 9.16 Million | 9 Million |
| Selling, General and Administrative Expenses | 1.46 Million | 1.58 Million | - | 1.32 Million | 1.43 Million | 1.63 Million |
| Research and Development Expenses | 9.81 Million | 8.05 Million | - | 8.22 Million | 7.73 Million | 7.37 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 11.29 Million | 9.64 Million | 38.07 Million | 9.56 Million | 9.16 Million | 9 Million |
| Operating Income | -11.29 Million | -9.64 Million | -38.07 Million | -9.56 Million | -9.16 Million | -9 Million |
| Interest Expense | 1.26 Million | 1.05 Million | -2.79 Million | 847 Thousand | 835 Thousand | 650 Thousand |
| Income Tax Expense | - | -34.27 Thousand | - | -2.27 Million | 835 Thousand | 666 Thousand |
| Earnings before Tax | -12.37 Million | -11.48 Million | -41.06 Million | -9.99 Million | -10.42 Million | -9.11 Million |
| Net Income | -12.37 Million | -11.48 Million | -41.06 Million | -9.99 Million | -10.42 Million | -9.11 Million |
| Earnings Per Share Basic | -0.20 | -0.19 | - | -0.16 | -0.17 | -0.15 |
| Earnings Per Share Diluted | -0.20 | -0.19 | - | -0.16 | -0.17 | -0.15 |
| Weighted Average Shares Outstanding | 62.23 Million | 61.97 Million | 60.15 Million | 61.85 Million | 59.7 Million | 59.58 Million |
| Weighted Average Shares Outstanding (Diluted) | 62.23 Million | 61.97 Million | 60.15 Million | 61.85 Million | 59.7 Million | 59.58 Million |
| Gross Margin | - | - | - | 0.89 | - | - |
| EBIT Margin | - | - | - | -119.40 | - | - |
| Profit Margin | - | - | - | -124.96 | - | - |
| EBITDA | -11.28 Million | -9.63 Million | - | -9.55 Million | -9.09 Million | -8.95 Million |
| Earnings Before Tax Margin | - | - | - | -119.51 | - | - |
CTRYY
EDD
INNPF
SMAWF
FSS
603396